MikaelMalmqvist Atlas Antibodies ABSweden

MikaelMalmqvist
With over five years at the company, Mikael Malmquist has led product development for next-generation immunoassay test platforms, overseeing experimental design, laboratory optimisation, data analysis, and scientific presentations. Mikael Malmquist played a pivotal role in the successful launch of the AtlasPlex kit solution, helping researchers overcome multiplex IHC hurdles and expand the possibilities of multi-target staining. Known for an analytical and curious approach, Mikael Malmquist is passionate about science and discovery.

Tuesday 09 June 2026

Time Session
08:30
09:15
Join Atlas Antibodies for an exploration into the evolution of spatial proteomics, rooted in the 20-year legacy of the Human Protein Atlas (HPA). This symposium demonstrates how the rigorously validated primary antibodies that built the HPA are now driving advanced functional discovery in cancer research. The session will cover two key technical workflows: Atlasplex, a streamlined solution for targeted 3-5 marker multiplexing, and Molboolean, an innovative technology using rolling circle amplification to detect protein-protein interactions in situ. Attendees will learn how to bridge the gap between static tissue maps and dynamic functional insights, utilizing high-certainty reagents to characterize cellular "neighborhoods" and molecular interactions. Whether you are looking to optimize your multiplexing efficiency or investigate protein-protein complexes, this session provides a practical roadmap for turning routine IHC into high-dimensional data.
Room F1+2+3